WATERTOWN, Mass., July 16, 2026 (GLOBE NEWSWIRE) -- Diagonal Therapeutics, a clinical-stage biotechnology company developing disease-modifying clustering antibodies that correct dysregulated signaling ...
WATERTOWN, Mass., June 18, 2025 (GLOBE NEWSWIRE) -- Diagonal Therapeutics, a biotechnology company focused on correcting dysregulated signaling with clustering antibodies that address the underlying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results